Found: 27
Select item for more details and to access through your institution.
Retraction Note: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.839945
- By:
- Publication type:
- Article
Activating Natural Killer Cell Receptors, Selectins, and Inhibitory Siglecs Recognize Ebolavirus Glycoprotein.
- Published in:
- Journal of Innate Immunity, 2022, v. 14, n. 2, p. 135, doi. 10.1159/000517628
- By:
- Publication type:
- Article
The Role of Janus Kinase/STAT3 Pathway in Hematologic Malignancies With an Emphasis on Epigenetics.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.703883
- By:
- Publication type:
- Article
Cloning and Embryo Splitting in Mammalians: Brief History, Methods, and Achievements.
- Published in:
- Stem Cells International, 2021, p. 1, doi. 10.1155/2021/2347506
- By:
- Publication type:
- Article
Re-Expression of Poly/Oligo-Sialylated Adhesion Molecules on the Surface of Tumor Cells Disrupts Their Interaction with Immune-Effector Cells and Contributes to Pathophysiological Immune Escape.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5203, doi. 10.3390/cancers13205203
- By:
- Publication type:
- Article
CAR‐NK cell in cancer immunotherapy; A promising frontier.
- Published in:
- Cancer Science, 2021, v. 112, n. 9, p. 3427, doi. 10.1111/cas.14993
- By:
- Publication type:
- Article
Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.699746
- By:
- Publication type:
- Article
Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02420-8
- By:
- Publication type:
- Article
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02283-z
- By:
- Publication type:
- Article
Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 viruses.
- Published in:
- IUBMB Life, 2021, v. 73, n. 8, p. 1005, doi. 10.1002/iub.2516
- By:
- Publication type:
- Article
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02283-z
- By:
- Publication type:
- Article
Up‐regulation of KISS1 as a novel target of Let‐7i in melanoma serves as a potential suppressor of migration and proliferation in vitro.
- Published in:
- Journal of Cellular & Molecular Medicine, 2021, v. 25, n. 14, p. 6864, doi. 10.1111/jcmm.16695
- By:
- Publication type:
- Article
A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.681984
- By:
- Publication type:
- Article
CAR-NK Cell: A New Paradigm in Tumor Immunotherapy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.673276
- By:
- Publication type:
- Article
Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02378-7
- By:
- Publication type:
- Article
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02283-z
- By:
- Publication type:
- Article
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02251-7
- By:
- Publication type:
- Article
Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02265-1
- By:
- Publication type:
- Article
CAR T cells in solid tumors: challenges and opportunities.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-020-02128-1
- By:
- Publication type:
- Article
Expression and Purification of a Bispecific Antibody against CD16 and Hemagglutinin Neuraminidase (HN) in E. Coli for Cancer Immunotherapy.
- Published in:
- Reports of Biochemistry & Molecular Biology, 2020, v. 9, n. 1, p. 50, doi. 10.29252/rbmb.9.1.50
- By:
- Publication type:
- Article
Expression and Purification of a Bispecific Antibody against CD16 and Hemagglutinin Neuraminidase (HN) in E. Coli for Cancer Immunotherapy.
- Published in:
- Reports of Biochemistry & Molecular Biology, 2020, v. 8, n. 4, p. 50
- By:
- Publication type:
- Article
Modulation of NKp30- and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin.
- Published in:
- PLoS Pathogens, 2011, v. 7, n. 8, p. 1, doi. 10.1371/journal.ppat.1002195
- By:
- Publication type:
- Article
Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool.
- Published in:
- Glycobiology, 2008, v. 18, n. 1, p. 28, doi. 10.1093/glycob/cwm125
- By:
- Publication type:
- Article
Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 12, p. 2625, doi. 10.1002/ijc.22579
- By:
- Publication type:
- Article